feedback welcome

Citalopram-paroxetine

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[draft revision][draft revision]
Line 3: Line 3:
| to = paroxetine
| to = paroxetine
| stop =  
| stop =  
-
* Gradually reduce dosage of citalopram/escitalopram to a maximum of 20 mg/ day resp. 10 mg/day, when this dosage is respectively > 20 mg/day and > 10 mg/day.  
+
* Gradually reduce dosage of citalopram to a maximum of 20 mg/day when this dosage is > 20 mg/day.
-
* When a dosage of 20 mg/day, resp. 10 mg/day, is reached, stop administration.
+
* When a dosage of 20 mg/day, is reached, stop administration.
| start =  
| start =  
* No wash-out period is needed.
* No wash-out period is needed.
* Start paroxetine the next day in normal dosage of 20 mg/day.
* Start paroxetine the next day in normal dosage of 20 mg/day.
| info =  
| info =  
-
* The same applies to [[escitalopram]].
 
* {{theorSS}}
* {{theorSS}}
}}
}}

Revision as of 20:40, 4 March 2010

Citalopram
Type Antidepressant
Group SSRI
links
ATC-code N06AB04
Medscape Citalopram
PubChem 2771
PubMed Citalopram
Kompas (Dutch) citalopram
Wikipedia citalopram
paroxetine
Type Antidepressant
Group SSRI
links
Medscape paroxetine
PubChem 43815
PubMed paroxetine
Kompas (Dutch) paroxetine
Wikipedia paroxetine

Switch medication from citalopram to paroxetine.

Nietinrijdenbord.png Stop citalopram
Eenrichtingbord.png Start paroxetine
Infobord.png More information
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About